Edition:
United States

Neurotrope Inc (NTRP.OQ)

NTRP.OQ on NASDAQ Stock Exchange Capital Market

9.86USD
22 Jun 2018
Change (% chg)

$0.45 (+4.78%)
Prev Close
$9.41
Open
$9.48
Day's High
$9.86
Day's Low
$9.42
Volume
18,176
Avg. Vol
6,275
52-wk High
$11.19
52-wk Low
$3.41

Chart for

About

Neurotrope, Inc., formerly BlueFlash Communications, Inc., is a biopharmaceutical company with its product candidates in pre-clinical and clinical development. The Company is focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease (AD), which is in the... (more)

Overall

Beta: 2.87
Market Cap(Mil.): $73.94
Shares Outstanding(Mil.): 7.91
Dividend: --
Yield (%): --

Financials

  NTRP.OQ Industry Sector
P/E (TTM): -- 38.48 11.53
EPS (TTM): -1.47 -- --
ROI: -64.93 15.25 18.30
ROE: -64.93 16.67 19.56

BRIEF-Neurotrope's Bryostatin Improves Cognition In Patients

* NEUROTROPE'S BRYOSTATIN IMPROVES COGNITION IN PATIENTS WITH ADVANCED ALZHEIMER'S DISEASE BASED ON FURTHER ANALYSIS OF PHASE 2 CLINICAL TRIAL DATA Source text for Eikon: Further company coverage:

Jan 05 2018

Earnings vs. Estimates